Cluster Infectious Diseases, Department of Research, Amsterdam Public Health Service, Amsterdam, the Netherlands.
Euro Surveill. 2010 Apr 15;15(15):19539.
Many individuals with hepatitis C virus (HCV) infection are undiagnosed. This study evaluates a risk assessment questionnaire, developed for use online to target blood-screening for HCV. Two hundred and eighty-nine patients with known HCV status completed a written questionnaire on prominent HCV risk factors. Questionnaires generated advice to seek testing if at least one risk factor was reported. Agreement of the testing advice with the HCV status of respondents was evaluated. Subsequently, we validated our questionnaire among 985 patients of an outpatient clinic for sexually transmitted infections. The post-test-probability-of-disease (PTPD) and diagnostic gain (PTPD minus prior probability of disease) were calculated. The questionnaire's sensitivity and specificity were 84.6% and 63.8%, respectively, and higher in the STI clinic patients. The PTPD of positive testing advice was 72.5% given HCV prevalence of 53.0%, yielding a diagnostic gain of 19.5%. Applying the estimated prevalence in the general Dutch population (0.1-0.4%), and the anticipated prevalence in the online project (1.0-6.0%), yielded diagnostic gains of 0.13-0.53% and 1.3-7.0%, respectively. We conclude that our questionnaire succeeded in selecting at-risk individuals as its testing advice agreed well with the HCV status. We suggest that the questionnaire be used online as a selection tool for HCV blood-screening in the general population.
许多丙型肝炎病毒 (HCV) 感染者未被诊断出来。本研究评估了一种风险评估问卷,该问卷专为在线使用而开发,旨在针对 HCV 进行血液筛查。289 名已知 HCV 感染者完成了一份关于 HCV 主要危险因素的书面问卷。如果报告了至少一个危险因素,则问卷会提供进行检测的建议。评估了测试建议与受访者 HCV 状况的一致性。随后,我们在性传播感染门诊的 985 名患者中验证了我们的问卷。计算了疾病后验概率 (PTPD) 和诊断增益 (PTPD 减去疾病先验概率)。问卷的灵敏度和特异性分别为 84.6%和 63.8%,在性传播感染门诊患者中更高。阳性检测建议的 PTPD 为 72.5%,HCV 流行率为 53.0%,诊断增益为 19.5%。应用一般荷兰人群中的估计患病率 (0.1-0.4%) 和在线项目中的预期患病率 (1.0-6.0%),分别产生 0.13-0.53%和 1.3-7.0%的诊断增益。我们得出结论,我们的问卷成功地选择了处于风险中的个体,因为其测试建议与 HCV 状况非常吻合。我们建议在线使用问卷作为一般人群 HCV 血液筛查的选择工具。